Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Post by palinc2000on Feb 16, 2023 4:53pm
281 Views
Post# 35290828

February 28 th PR and CC

February 28 th PR and CCWe now know that the late date is not related to  expectations of getting an FDA ok for an amendment of the protocol in Phase 1 for TH 190 as some suggested.

Why then such a late date?
1--Maybe due to more time needed to finalise year end Financial Statements...Possible but unlikely imo
2-Waiting till the last minute to be able to pre announce First Quarter revenues ...hopefully to the upside but idk
3- Maybe they are in the midst ofnegotiating a deal in Nash with a parner  and they are hoping to be able to make an announcement  prior to Feb 28 


Not predicting anything but there is a reason for the delay and cant think of anything outside of the above

 

<< Previous
Bullboard Posts
Next >>